âš« Works by increasing the concentration of acetylcholine by inhibiting dopamine D2 receptors and acetylcholinesterase
âš« A promising gastroprokinetic agent for FD because of its efficacy without any significant adverse events'
âš« Regulates gastric motility and gastric emptying
âš« Unlike other prokinetic drugs that are utilized in the management of Functional Dyspepsia, Acorun shows little or no affinity for serotonin or dopamine D2 receptors2
âš« World's First Approved Treatment for Functional Dyspepsia in Patients Diagnosed by Rome III criteria2